152 related articles for article (PubMed ID: 31878112)
21. Gender differences in leukemia outcomes based on health care expenditures using estimates from the GLOBOCAN 2020.
Amini M; Sharma R; Jani C
Arch Public Health; 2023 Aug; 81(1):151. PubMed ID: 37605241
[TBL] [Abstract][Full Text] [Related]
22. Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis.
Huang J; Chan SC; Tin MS; Liu X; Lok VT; Ngai CH; Zhang L; Lucero-Prisno DE; Xu W; Zheng ZJ; Chiu PK; Ng AC; Enikeev D; Nicol D; Spiess PE; Laguna P; Teoh JY; Wong MCS
Eur Urol Oncol; 2022 Oct; 5(5):566-576. PubMed ID: 35863988
[TBL] [Abstract][Full Text] [Related]
23. The global cancer divide: relationships between national healthcare resources and cancer outcomes in high-income vs. middle- and low-income countries.
Batouli A; Jahanshahi P; Gross CP; Makarov DV; Yu JB
J Epidemiol Glob Health; 2014 Jun; 4(2):115-24. PubMed ID: 24857179
[TBL] [Abstract][Full Text] [Related]
24. Multiple Myeloma Incidence and Mortality Around the Globe; Interrelations Between Health Access and Quality, Economic Resources, and Patient Empowerment.
Ludwig H; Novis Durie S; Meckl A; Hinke A; Durie B
Oncologist; 2020 Sep; 25(9):e1406-e1413. PubMed ID: 32335971
[TBL] [Abstract][Full Text] [Related]
25. Patterns of better breast cancer care in countries with higher human development index and healthcare expenditure: Insights from GLOBOCAN 2020.
Azadnajafabad S; Saeedi Moghaddam S; Mohammadi E; Delazar S; Rashedi S; Baradaran HR; Mansourian M
Front Public Health; 2023; 11():1137286. PubMed ID: 37124828
[TBL] [Abstract][Full Text] [Related]
26. Global Trends of Bladder Cancer Incidence and Mortality, and Their Associations with Tobacco Use and Gross Domestic Product Per Capita.
Teoh JY; Huang J; Ko WY; Lok V; Choi P; Ng CF; Sengupta S; Mostafid H; Kamat AM; Black PC; Shariat S; Babjuk M; Wong MC
Eur Urol; 2020 Dec; 78(6):893-906. PubMed ID: 32972792
[TBL] [Abstract][Full Text] [Related]
27. Favorable Mortality-to-Incidence Ratio Trends of Lung Cancer in Countries with High Computed Tomography Density.
Wang YT; Chen BS; Wu HR; Chang YC; Yu CY; Sung WW
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837522
[No Abstract] [Full Text] [Related]
28. Association of Human Development Index with global bladder, kidney, prostate and testis cancer incidence and mortality.
Greiman AK; Rosoff JS; Prasad SM
BJU Int; 2017 Dec; 120(6):799-807. PubMed ID: 28480994
[TBL] [Abstract][Full Text] [Related]
29. International variations and trends in testicular cancer incidence and mortality.
Znaor A; Lortet-Tieulent J; Jemal A; Bray F
Eur Urol; 2014 Jun; 65(6):1095-106. PubMed ID: 24268506
[TBL] [Abstract][Full Text] [Related]
30. Global trends in testicular cancer incidence and mortality.
Rosen A; Jayram G; Drazer M; Eggener SE
Eur Urol; 2011 Aug; 60(2):374-9. PubMed ID: 21612857
[TBL] [Abstract][Full Text] [Related]
31. Melanoma prognosis in Europe: far from equal.
Forsea AM; Del Marmol V; Stratigos A; Geller AC
Br J Dermatol; 2014 Jul; 171(1):179-82. PubMed ID: 24588115
[TBL] [Abstract][Full Text] [Related]
32. Mortality-to-Incidence Ratio for Nasopharyngeal Carcinoma Is Associated with Health Expenditure.
Dong C; Fu JT; Wu HR; Chao YC; Chen YC; Sung WW; Chen WJ; Chen CJ
Healthcare (Basel); 2022 Aug; 10(9):. PubMed ID: 36141227
[TBL] [Abstract][Full Text] [Related]
33. Gross domestic product and health expenditure associated with incidence, 30-day fatality, and age at stroke onset: a systematic review.
Sposato LA; Saposnik G
Stroke; 2012 Jan; 43(1):170-7. PubMed ID: 22033985
[TBL] [Abstract][Full Text] [Related]
34. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.
Wong MC; Goggins WB; Wang HH; Fung FD; Leung C; Wong SY; Ng CF; Sung JJ
Eur Urol; 2016 Nov; 70(5):862-874. PubMed ID: 27289567
[TBL] [Abstract][Full Text] [Related]
35. Cancer mortality-to-incidence ratio as an indicator of cancer management outcomes in Organization for Economic Cooperation and Development countries.
Choi E; Lee S; Nhung BC; Suh M; Park B; Jun JK; Choi KS
Epidemiol Health; 2017; 39():e2017006. PubMed ID: 28171715
[TBL] [Abstract][Full Text] [Related]
36. International geographic correlation study of the prevalence of disorders of male reproductive health.
Serrano T; Chevrier C; Multigner L; Cordier S; Jégou B
Hum Reprod; 2013 Jul; 28(7):1974-86. PubMed ID: 23670171
[TBL] [Abstract][Full Text] [Related]
37. Improvement in the Mortality-to-Incidence Ratios for Gastric Cancer in Developed Countries With High Health Expenditures.
Yang TW; Wang CC; Hung WC; Liu YH; Sung WW; Tsai MC
Front Public Health; 2021; 9():713895. PubMed ID: 34485236
[TBL] [Abstract][Full Text] [Related]
38. Incidence and Mortality of Testicular Cancer and Relationships with Development in Asia.
Sadeghi M; Ghoncheh M; Mohammadian-Hafshejani A; Gandomani HS; Rafiemanesh H; Salehiniya H
Asian Pac J Cancer Prev; 2016; 17(9):4251-4257. PubMed ID: 27797227
[TBL] [Abstract][Full Text] [Related]
39. Radiation Therapy Availability in Africa and Latin America: Two Models of Low and Middle Income Countries.
Bishr MK; Zaghloul MS
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):490-498. PubMed ID: 30005945
[TBL] [Abstract][Full Text] [Related]
40. Wealth, Health Expenditure, and Cancer: A National Perspective.
Chahoud J; Semaan A; Rieber A
J Natl Compr Canc Netw; 2016 Aug; 14(8):972-8. PubMed ID: 27496113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
